As Wayfair (W) Market Valuation Rose, Holder Battery Partners Ix Has Trimmed Stake by $72.92 Million; Teva Pharmaceutical Inds LTD (TEVA) Holding Maintained by Capital Management Corp

November 15, 2017 - By Neil V. Hobbs

Battery Partners Ix Llc decreased its stake in Wayfair Inc (W) by 67.87% based on its latest 2017Q2 regulatory filing with the SEC. Battery Partners Ix Llc sold 959,500 shares as the company’s stock rose 54.30% with the market. The institutional investor held 454,166 shares of the catalog and specialty distribution company at the end of 2017Q2, valued at $34.92M, down from 1.41 million at the end of the previous reported quarter. Battery Partners Ix Llc who had been investing in Wayfair Inc for a number of months, seems to be less bullish one the $5.70 billion market cap company. The stock increased 3.72% or $2.33 during the last trading session, reaching $64.9. About 940 shares traded. Wayfair Inc (NYSE:W) has risen 54.80% since November 15, 2016 and is uptrending. It has outperformed by 38.10% the S&P500.

Capital Management Corp increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 5.92% based on its latest 2017Q2 regulatory filing with the SEC. Capital Management Corp bought 14,074 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 251,784 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $8.36M, up from 237,710 at the end of the previous reported quarter. Capital Management Corp who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $11.95B market cap company. The stock declined 0.94% or $0.11 reaching $11.64 on the news. About 52,534 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since November 15, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Capital Management Corp, which manages about $401.58 million and $335.02M US Long portfolio, decreased its stake in Albemarle Corp (NYSE:ALB) by 11,865 shares to 82,284 shares, valued at $8.68M in 2017Q2, according to the filing. It also reduced its holding in Las Vegas Sands Corp (NYSE:LVS) by 61,074 shares in the quarter, leaving it with 185,313 shares, and cut its stake in Sanfilippo John B & Son Inc (NASDAQ:JBSS).

Among 31 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 7 Sell and 16 Hold. Therefore 26% are positive. Teva Pharma had 111 analyst reports since July 21, 2015 according to SRatingsIntel. Maxim Group maintained the stock with “Buy” rating in Wednesday, January 4 report. The company was maintained on Tuesday, January 31 by Barclays Capital. The rating was downgraded by Citigroup to “Neutral” on Wednesday, August 16. The firm has “Hold” rating by Maxim Group given on Friday, January 6. Piper Jaffray maintained it with “Hold” rating and $2300 target in Thursday, August 3 report. Mizuho maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Wednesday, November 16 with “Neutral” rating. Nomura initiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Tuesday, September 29 with “Neutral” rating. The firm has “Buy” rating given on Friday, June 16 by Mizuho. Morgan Stanley maintained it with “Overweight” rating and $69 target in Tuesday, May 3 report. Maxim Group maintained the stock with “Hold” rating in Monday, February 13 report.

More news for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) were recently published by: Investorplace.com, which released: “Teva Pharmaceutical (TEVA) Stock Sinks on Lowered Outlook” on November 02, 2017. Investorplace.com‘s article titled: “Tuesday’s Vital Data: Alibaba Group Holding Ltd (BABA), Teva Pharmaceutical …” and published on November 07, 2017 is yet another important article.

More news for Wayfair Inc (NYSE:W) were recently published by: Fool.com, which released: “Wayfair Inc’s Growth Remains Strong, but Wall Street Worries About Profitability” on November 03, 2017. Fool.com‘s article titled: “Why Wayfair Inc. Stock Plunged Today” and published on November 02, 2017 is yet another important article.

Among 29 analysts covering Wayfair LLC (NYSE:W), 15 have Buy rating, 1 Sell and 13 Hold. Therefore 52% are positive. Wayfair LLC had 71 analyst reports since July 31, 2015 according to SRatingsIntel. Maxim Group maintained Wayfair Inc (NYSE:W) rating on Wednesday, May 10. Maxim Group has “Buy” rating and $75 target. The rating was upgraded by Citigroup to “Buy” on Wednesday, January 20. The stock of Wayfair Inc (NYSE:W) has “Buy” rating given on Tuesday, August 8 by Cowen & Co. Oppenheimer maintained Wayfair Inc (NYSE:W) rating on Friday, August 4. Oppenheimer has “Buy” rating and $8800 target. The rating was downgraded by Raymond James to “Outperform” on Tuesday, March 22. The firm has “Hold” rating given on Monday, June 19 by Maxim Group. The stock of Wayfair Inc (NYSE:W) has “Buy” rating given on Wednesday, November 9 by Maxim Group. Canaccord Genuity maintained the stock with “Buy” rating in Sunday, October 1 report. The rating was maintained by Stifel Nicolaus on Thursday, November 2 with “Buy”. The rating was maintained by Piper Jaffray with “Overweight” on Thursday, February 25.

Analysts await Wayfair Inc (NYSE:W) to report earnings on February, 22. They expect $-0.70 earnings per share, down 37.25% or $0.19 from last year’s $-0.51 per share. After $-0.88 actual earnings per share reported by Wayfair Inc for the previous quarter, Wall Street now forecasts -20.45% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.